Alkahest

Digital

pharmaphorum grabbed a moment with Alkahest Head of Data Science Benoit LeHallier after his talk at Frontiers Health.

R&D

Through a pioneering initiative called Chronos-PD, Grifols is partnering with the Michael J.

News

Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.